CathVision today announced significant clinical and scientific progress in Pulsed Field Ablation (PFA) with its PFAnalyzertm ...

CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.

A busy week of quarterly results delivered regulatory milestones, broker upgrades and mixed share-price moves across ASX healthcare. ... Read More The post Scott Power: Quarterly results build ...

ASCs are entering a new phase of growth driven by new care pathways, staffing models and site-of-care shifts. From partnerships with orthopedic walk-in clinics to CMS coverage for EP ablation, here ...

Abbott supported its CE mark approval with data from its FOCALFLEX CE mark study. The global clinical trial, conducted across ...

Corify Care introduces whole-heart mapping technology, delivering a global view of cardiac Arrhythmias in a single beat: Madrid Friday, January 30, 2026, 11:00 Hrs [IST] Corify Ca ...

Medtronic plc is rated a Buy with solid growth prospects, balance sheet remains A-rated and shares are undervalued. Learn ...

Fourth-quarter GAAP diluted EPS of $1.01; adjusted diluted EPS of $1.50 reflects growth of 12 percent Full-year 2025 GAAP diluted EPS of $3.72; adjusted diluted ...

Abbott begins patient enrollment in LESS-VT study to evaluate ablation as frontline treatment for complex cardiac arrhythmia: Abbott Park, Illinois Thursday, November 22, 2018, 09 ...

Johnson & Johnson (NYSE:JNJ) Q4 2025 Earnings Call Transcript January 21, 2026 Johnson & Johnson reports earnings inline with ...

Abbott's TactiFlex Duo Ablation Catheter, Sensor Enabled, is designed with dual-energy to treat atrial fibrillation patients with the most challenging cases It can ...

Good afternoon. Thank you all for joining us today. My name is Henry Jiang. I'm with the banking team here at JPMorgan. And today, I have the pleasure of introducing Pulse Biosciences. Presenting ...